These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22005110)

  • 1. Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
    Trébucq A; Enarson DA; Chiang CY; Van Deun A; Harries AD; Boillot F; Detjen A; Fujiwara PI; Graham SM; Monedero I; Rusen ID; Rieder HL
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1567-72. PubMed ID: 22005110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
    Ciftçi IH; Aslan MH; Aşık G
    Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xpert MTB/RIF®, a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis.
    Bowles EC; Freyée B; van Ingen J; Mulder B; Boeree MJ; van Soolingen D
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):988-9. PubMed ID: 21682978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Xpert® MTB/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden.
    Kim SY; Kim H; Kim SY; Ra EK; Joo SI; Shin S; Seong MW; Yoo CG; Kim EC; Park SS
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1471-6. PubMed ID: 22981162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis.
    Chang K; Lu W; Wang J; Zhang K; Jia S; Li F; Deng S; Chen M
    J Infect; 2012 Jun; 64(6):580-8. PubMed ID: 22381459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Xpert(®) MTB/RIF assay: diagnosis and treatment outcomes in rifampicin-resistant tuberculosis.
    Kim YW; Seong MW; Kim TS; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1216-21. PubMed ID: 26459536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic observation drug-susceptibility assay vs. Xpert
    Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
    Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.
    Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S
    J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.
    Metcalfe JZ; Makumbirofa S; Makamure B; Sandy C; Bara W; Mason P; Hopewell PC
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):882-9. PubMed ID: 27287639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries.
    Ardizzoni E; Fajardo E; Saranchuk P; Casenghi M; Page AL; Varaine F; Kosack CS; Hepple P
    PLoS One; 2015; 10(12):e0144656. PubMed ID: 26670929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis.
    Pantoja A; Fitzpatrick C; Vassall A; Weyer K; Floyd K
    Eur Respir J; 2013 Sep; 42(3):708-20. PubMed ID: 23258774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.
    Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F
    PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys.
    Rigouts L; Hoza AS; De Rijk P; Torrea G; Chonde TM; Basra D; Zignol M; van Leth F; Egwaga SM; Van Deun A
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):959-65. PubMed ID: 21682972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Xpert MTB/RIF Assay and Real-time PCR for the Detection of Mycobacterium tuberculosis.
    Kim MJ; Nam YS; Cho SY; Park TS; Lee HJ
    Ann Clin Lab Sci; 2015; 45(3):327-32. PubMed ID: 26116598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xpert® MTB/RIF diagnosed disseminated smear-negative MDR-TB in a sub-district hospital in India.
    Dorjee K; Salvo F; Dierberg KL
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1560-1. PubMed ID: 23044453
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis.
    Williamson DA; Basu I; Bower J; Freeman JT; Henderson G; Roberts SA
    Diagn Microbiol Infect Dis; 2012 Oct; 74(2):207-9. PubMed ID: 22819240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil.
    Pereira GR; Barbosa MS; Dias NJD; Almeida CPB; Silva DR
    PLoS One; 2018; 13(3):e0193988. PubMed ID: 29518135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.